Cardiology News and Research

Latest Cardiology News and Research

CDC MMR/autism study - wrong questions asked, wrong children studied, wrong conclusions NAA says

A Centers for Disease Control and Prevention (CDC) study released today claims there is no link between the MMR vaccine and autism. The National Autism Association (NAA) says this study does nothing to dispel the growing public concern over a vaccine-autism connection and raises several questions concerning design and methodology.

4 Sep 2008

Diffusion Pharmaceuticals initiates phase I/II clinical trial in patients with peripheral arterial disease

Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing new drugs for the treatment of unmet medical needs, announced today that it has begun to enroll patients in a Phase I/II clinical trial of its lead drug candidate trans sodium crocetinate (TSC).

3 Sep 2008

A home early warning system for cardiac patients

Heart disease is the number one cause of death in Europe and early diagnosis is essential to save lives. Monitoring the heart's rhythm and electrical activity in real time using an electrocardiogram (ECG) provides vital information about abnormalities and gives clues to the nature of a problem. Some cardiac conditions need long-term monitoring - inconvenient for patients as it requires them to be away from their everyday environment for indeterminate periods of time.

3 Sep 2008

Single embryo advice to IVF clinics will reduce the number of multiple births

Experts in the UK are advising that wherever possible, only one embryo per IVF cycle should be transferred in order to cut the rate of multiple births.

3 Sep 2008

Concern raised again about heart drugs Zetia and Vytorin

The editors of the New England Journal of Medicine have raised concern regarding the cholesterol-lowering drugs Zetia and Vytorin.

3 Sep 2008

Older people can improve their memory and postpone dementia with exercise

A study by Australian researchers has found that regular, moderate exercise may help improve memory in older people and delay the onset of dementia.Older people can improve their memory and postpone dementia with exercise

3 Sep 2008

Further analysis from ATHENA study showed Multaq (Dronedarone) reduced risk of stroke in patients with atrial fibrillation

The results of a post-hoc analysis of the data from the ATHENA study were presented today at the clinical trial update session of the European Society of Cardiology congress 2008, in Munich, Germany.

3 Sep 2008

Hurricane Katrina increased mental and physical health problems in New Orleans by up to three times

Half the residents of New Orleans were suffering from poor mental and physical health more than a year after their homes and community were devastated by Hurricane Katrina in August 2005, according to research published in the September issue of the UK-based Journal of Clinical Nursing.

3 Sep 2008

Men who have too much calcium in their bloodstreams may increase risk of fatal prostate cancer

Men who have too much calcium in their bloodstreams may have an increased risk of fatal prostate cancer, according to a new analysis from Wake Forest University School of Medicine and the University of Wisconsin.

3 Sep 2008

Just a little exercise each day helps prevent memory deterioration

West Australian health experts are urging older people to get active after proving for the first time that just 20 minutes of activity each day can prevent memory deterioration.

2 Sep 2008

Advances in cell therapy bring cure for diabetes step closer

Affecting eight percent of America's population, diabetes can lead to blindness, kidney failure, strokes and heart disease. Thanks to Tel Aviv University researchers, a new cure -- based on advances in cell therapy -- may be within reach.

2 Sep 2008

Fibrex medical reports positive phase II results for peptide for the treatment of reperfusion injury

Fibrex Medical has announced positive Phase II results for FX06, a peptide for the treatment of reperfusion injury - the damage to heart muscle that results from remedial treatment following a heart attack. The results will be presented at the ESC Congress today in Munich, Germany.

2 Sep 2008

First patient enrolled in study evaluating S.M.A.R.T. Nitinol self-expandable stent

Cordis Corporation has announced the first patient enrollment in the STROLL trial, which will evaluate the safety and efficacy of the S.M.A.R.T. Nitinol Self-Expandable Stent System in treating patients with obstructive superficial femoral artery (SFA) disease, also known as SFA atherosclerosis.

2 Sep 2008

Millions face undiagnosed heart risk in the UK say researchers after mass screening

One in three people with a high risk of developing cardiovascular disease (CVD) over the next 10 years have not been diagnosed, according to a major study in the September issue of IJCP, the International Journal of Clinical Practice.

2 Sep 2008

The role played by drug-eluting stents in reducing acute myocardial infarction

The safety debate about drug-eluting stents (DES) is still ongoing. In these times of uncertainty about DES safety, the study has shown that DES markedly improve long-term survival compared to modern bare-metal stents (BMS) implantation in patients with acute ST-segment elevation myocardial infarction (STEMI). In our four year investigation, DES demonstrated a significant reduction of mortality in this sick patient subset.

2 Sep 2008

Factor Xa inhibitor Apixaban and antiplatelet therapy after acute coronary syndrome

Data from a phase II study of an investigational drug designed to block formation of blood clots show potential for added protection against a second heart attack or stroke among patients who are already taking state-of-the-art prevention therapy.

2 Sep 2008

Fibrin-derived peptide FX06 reduces cardiac reperfusion injury

Data presented today at the European Society of Cardiology Congress demonstrates the effectiveness of a peptide called FX06 in preventing cardiac damage resulting from treatment following a heart attack.

2 Sep 2008

Overcoming poor response to standard oral antiplatelet agents

Existing practice surrounding many cardiovascular medications, including anti-hypertensive and lipid-lowering agents, is based on the evaluation of response to therapy. In cases where ideal therapeutic targets (which have been identified through several previous studies) are not met in the single individual, there is evidence to support the need to intensify standard treatment so as to achieve better control of the cardiovascular risk factor under treatment (e.g. blood pressure or cholesterol levels) as this translates into a better outcome.

2 Sep 2008

Results from the Simvastatin and Ezetimibe in aortic stenosis study

The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of intensive cholesterol lowering with the combination of simvastatin (40 mg daily) and ezetimibe (10 mg daily) in patients with aortic stenosis.

2 Sep 2008

Myocardial regeneration by intracoronary infusion in AMI (REGENT) randomized trial

REGENT is a multicenter, randomized trial for comparison of intracoronary infusion of bone marrow-derived unselected mononuclear cells (MNC) and selected CD34+CXCR4+ cells in 200 patients with acute myocardial infarction and reduced LVEF ¡Ü 40%.

2 Sep 2008

Cardiology News and Research

Latest Cardiology News and Research

CDC MMR/autism study - wrong questions asked, wrong children studied, wrong conclusions NAA says

Diffusion Pharmaceuticals initiates phase I/II clinical trial in patients with peripheral arterial disease

A home early warning system for cardiac patients

Single embryo advice to IVF clinics will reduce the number of multiple births

Concern raised again about heart drugs Zetia and Vytorin

Older people can improve their memory and postpone dementia with exercise

Further analysis from ATHENA study showed Multaq (Dronedarone) reduced risk of stroke in patients with atrial fibrillation

Hurricane Katrina increased mental and physical health problems in New Orleans by up to three times

Men who have too much calcium in their bloodstreams may increase risk of fatal prostate cancer

Just a little exercise each day helps prevent memory deterioration

Advances in cell therapy bring cure for diabetes step closer

Fibrex medical reports positive phase II results for peptide for the treatment of reperfusion injury

First patient enrolled in study evaluating S.M.A.R.T. Nitinol self-expandable stent

Millions face undiagnosed heart risk in the UK say researchers after mass screening

The role played by drug-eluting stents in reducing acute myocardial infarction

Factor Xa inhibitor Apixaban and antiplatelet therapy after acute coronary syndrome

Fibrin-derived peptide FX06 reduces cardiac reperfusion injury

Overcoming poor response to standard oral antiplatelet agents

Results from the Simvastatin and Ezetimibe in aortic stenosis study

Myocardial regeneration by intracoronary infusion in AMI (REGENT) randomized trial

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Cardiology News and Research

Latest Cardiology News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in